200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 254-60-4

254-60-4

254-60-4 | 1,8-Diazanaphthalene

CAS No: 254-60-4 Catalog No: AG0032NM MDL No:MFCD00059751

Product Description

Catalog Number:
AG0032NM
Chemical Name:
1,8-Diazanaphthalene
CAS Number:
254-60-4
Molecular Formula:
C8H6N2
Molecular Weight:
130.1466
MDL Number:
MFCD00059751
IUPAC Name:
1,8-naphthyridine
InChI:
InChI=1S/C8H6N2/c1-3-7-4-2-6-10-8(7)9-5-1/h1-6H
InChI Key:
FLBAYUMRQUHISI-UHFFFAOYSA-N
SMILES:
c1cnc2c(c1)cccn2
UNII:
043R04VL4M

Properties

Complexity:
102  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
130.053g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
130.15g/mol
Monoisotopic Mass:
130.053g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
25.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
Synthesis of a new series of pyridine and fused pyridine derivatives. Molecules (Basel, Switzerland) 20120911
Methyl 1-ethyl-7-methyl-4-oxo-1,4-di-hydro-1,8-naphthyridine-3-carboxyl-ate monohydrate. Acta crystallographica. Section E, Structure reports online 20120301
Enhancement of affinity in molecular recognition via hydrogen bonds by POSS-core dendrimer and its application for selective complex formation between guanosine triphosphate and 1,8-naphthyridine derivatives. Organic & biomolecular chemistry 20120107
Selective G-quadruplex DNA stabilizing agents based on bisquinolinium and bispyridinium derivatives of 1,8-naphthyridine. The Journal of organic chemistry 20120106
Towards crystal structure prediction of complex organic compounds--a report on the fifth blind test. Acta crystallographica. Section B, Structural science 20111201
1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease. Current topics in medicinal chemistry 20111101
7-Amino-1,8-naphthyridin-2(1H)-one monohydrate. Acta crystallographica. Section E, Structure reports online 20110901
Hg2+ recognition by triptycene-derived heteracalixarenes: selectivity tuned by bridging heteroatoms and macrocyclic cavity. Organic & biomolecular chemistry 20110821
2,6-Diamino-pyridinium tetra-phenyl-borate-1,2-bis-(5,7-dimethyl-1,8-naphthyridin-2-yl)diazene (1/1). Acta crystallographica. Section E, Structure reports online 20110501
Palladium(II) complexes based on 1,8-naphthyridine functionalized N-heterocyclic carbenes (NHC) and their catalytic activity. Dalton transactions (Cambridge, England : 2003) 20110114
A step further towards multitarget drugs for Alzheimer and neuronal vascular diseases: targeting the cholinergic system, amyloid-β aggregation and Ca(2+) dyshomeostasis. Current medicinal chemistry 20110101
Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors. International journal of molecular sciences 20110101
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & medicinal chemistry letters 20100801
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. Journal of medicinal chemistry 20100722
Intense one- and two-photon excited fluorescent bis(BF2) core complex containing a 1,8-naphthyridine derivative. Organic letters 20100702
2-Chloro-7-methyl-12-phenyldibenzo[b,g][1,8]naphthyridin-11(6H)-one. Acta crystallographica. Section E, Structure reports online 20100701
Synthesis, characterization, photoinduced isomerization, and spectroscopic properties of vinyl-1,8-naphthyridine derivatives and their copper(I) complexes. Inorganic chemistry 20100517
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. Journal of medicinal chemistry 20100422
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists. Journal of molecular modeling 20100401
[Molecular geometries and theoretical electronic spectra of four 1,8-naphthyridine derivatives]. Guang pu xue yu guang pu fen xi = Guang pu 20100301
2,7-Bis-(trichloro-meth-yl)-1,8-naphthyridine. Acta crystallographica. Section E, Structure reports online 20100301
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II. PloS one 20100101
Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking. International journal of molecular sciences 20100101
N'-[(E)-Benzyl-idene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide. Acta crystallographica. Section E, Structure reports online 20091201
Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives. Journal of enzyme inhibition and medicinal chemistry 20091001
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells. The Journal of pharmacy and pharmacology 20090801
2,7-Dimethyl-1,8-naphthyridine. Acta crystallographica. Section E, Structure reports online 20090801
Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines. Bioorganic & medicinal chemistry 20090701
2,2',4,4'-Tetra-methyl-7,7'-diazenediylbis(1,8-naphthyridin-1-ium) bis-(perchlorate). Acta crystallographica. Section E, Structure reports online 20090701
μ-Bis(5,7-dimethyl-1,8-naphthyridin-2-yl)diazene]bis-[difluoridoboron(III). Acta crystallographica. Section E, Structure reports online 20090701
1-Ethyl-N'-[(E)-4-hydroxy-benzyl-idene]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide. Acta crystallographica. Section E, Structure reports online 20090401
7-(2,2-Dimethylpropanamido)-2-methyl-1,8-naphthyridin-1-ium chloride monohydrate. Acta crystallographica. Section E, Structure reports online 20090201
A 1,8-naphthyridine-based fluorescent chemodosimeter for the rapid detection of Zn2+ and Cu2+. Organic letters 20081120
Synthesis of binuclear platinum complexes containing the ligands 8-naphthyridine, 2-aminopyridine, and 7-azaindolate. An experimental study of the steric hindrance of the bulky pentafluorophenyl ligands in the synthesis of binuclear complexes. Inorganic chemistry 20081006
2,2'-Dimethyl-7,7'-(methyl-enediimino)di-1,8-naphthyridin-1-ium bis-(perchlorate). Acta crystallographica. Section E, Structure reports online 20080901
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model. Bioorganic & medicinal chemistry letters 20080601
Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyridine antagonists toward bovine adenosine receptors. Journal of enzyme inhibition and medicinal chemistry 20080601
Naphthyridine-based helical foldamers and macrocycles: synthesis, cation binding, and supramolecular assemblies. The Journal of organic chemistry 20080404
cis,trans-Dicarbonyl-dichlorido[2-(2-pyrid-yl)-1,8-naphthyridine-κN,N]ruthenium(II). Acta crystallographica. Section E, Structure reports online 20080301
One-pot solvent free synthesis and DNA binding studies of thieno[2,3-b]-1,8-naphthyridines. Preparative biochemistry & biotechnology 20080101
Effect of an alkyl amino group on the binding of 1,8-naphthyridines to AP site-containing DNA duplexes. Nucleic acids symposium series (2004) 20080101
Dichloridobis(7-amino-2,4-dimethyl-1,8-naphthyridine-κN,N')cobalt(II) methanol disolvate. Acta crystallographica. Section E, Structure reports online 20080101
Bis(7-amino-2,4-dimethyl-1,8-naphthyridine)dinitratocadmium(II). Acta crystallographica. Section E, Structure reports online 20080101
7-Acetyl-amino-2,4-dimethyl-1,8-naphthyridine. Acta crystallographica. Section E, Structure reports online 20080101
7-[4-(5,7-Dimethyl-1,8-naphthyridin-2-yl-oxy)phen-oxy]-2,4-dimethyl-1,8-naphthyridine methanol disolvate. Acta crystallographica. Section E, Structure reports online 20080101
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. Bioorganic & medicinal chemistry letters 20071201
Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anti-cancer agents in medicinal chemistry 20071101
Photochromism of photoenolizable ketones in quinoline and 1,8-naphthyridine series studied by time-resolved absorption spectroscopy. The journal of physical chemistry. A 20070315
Oxacalixarenes and oxacyclophanes containing 1,8-naphthyridines: a new class of molecular tweezers with concave-surface functionality. Chemical communications (Cambridge, England) 20070314
Synthesis and spectral investigations of manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II) complexes of new polydentate ligands containing a 1,8-naphthyridine moiety. Molecules (Basel, Switzerland) 20061221
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study. Journal of inflammation (London, England) 20060101
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. Bioorganic & medicinal chemistry letters 20051015
Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation. Toxicology letters 20050704
Tetrakis(mu(2)-1,8-naphthyridine)-1:2kappa(4)N:N';3:4kappa(4)N:N'-bis(mu(2)-salicylato)-1:4kappa(2)O:O';2:3kappa(2)O:O'-tetrakis(salicylic acid)-1kappaO,2kappaO,3kappaO,4kappaO-tetrasilver(I)(4 Ag-Ag). Acta crystallographica. Section C, Crystal structure communications 20050601
Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid. Bioorganic & medicinal chemistry 20050215
Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents. Bioorganic & medicinal chemistry letters 20040621
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants. Bioorganic & medicinal chemistry letters 20040621
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives. Journal of medicinal chemistry 20040603
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors. Bioorganic & medicinal chemistry 20040415
Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2. Journal of medicinal chemistry 20040408
Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. Bioorganic & medicinal chemistry letters 20040322
Modeling the syn disposition of nitrogen donors at the active sites of carboxylate-bridged diiron enzymes. Enforcing dinuclearity and kinetic stability with a 1,2-diethynylbenzene-based ligand. Inorganic chemistry 20031229
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists. Bioorganic & medicinal chemistry 20031117
Synthesis of 3- or 4-phenyl-1,8-naphthyridine derivatives and evaluation of antimycobacterial and antimicrobial activity. Farmaco (Societa chimica italiana : 1989) 20030901
Synthesis of variously substituted 1,8-naphthyridine derivatives and evaluation of their antimycobacterial activity. Farmaco (Societa chimica italiana : 1989) 20020801
Synthesis and pharmacological activities of 1,8-naphthyridine derivatives. Biological & pharmaceutical bulletin 20020601
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X. European journal of medicinal chemistry 20010101

© 2019 Angene International Limited. All rights Reserved.